1.08
price down icon8.47%   -0.10
pre-market  Vorhandelsmarkt:  1.10   0.02   +1.85%
loading

Finanzdaten der Atossa Therapeutics Inc-Aktie (ATOS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
21.93%
9.04
7.414 7.151 6.385 7.105
Operating Income/Loss
21.93%
-9.04
-7.414 -7.151 -6.385 -7.105
Income/Loss From Continuing Operations Before Tax
25.38%
-8.423
-6.718 -6.347 -7.23 -6.049
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
25.38%
-8.423
-6.718 -6.347 -7.23 -6.049
Net Income/Loss
25.38%
-8.423
-6.718 -6.347 -7.23 -6.049
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
129.17
129.17 0.2505 125.77 125.73
Diluted Average Shares
0.00%
129.17
129.17 0.2505 125.77 125.73
Basic Earnings Per Share
40.00%
-0.07
-0.05 -0.05 -0.06 -0.05
Diluted Earnings Per Share
40.00%
-0.07
-0.05 -0.05 -0.06 -0.05
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Kapitalisierung:     |  Volumen (24h):